Organisation paid for research Program year 2023 Source: CMS Open Payments

Sharp Healthcare

Neither a doctor nor a teaching hospital

Research payments

$34,731

7 payments

Through program year 2023, Sharp Healthcare is reported as receiving $34,731 in research payments, across 7 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2023	Research	$14	1
2021	Research	$362	1
2020	Research	$24,031	2
2019	Research	$10,324	3

Breakdown

Who paid Research payments · program years 2019–2023

Octapharma USA, Inc. $22,765 1 payment
Incyte Corporation $6,020 2 payments
Medtronic USA, Inc. $4,304 1 payment
Eli Lilly and Company $1,642 3 payments

Studies the money was for Research payments · program years 2019–2023

Cutaquig Registry $22,765 1 payment
A Phase 2, Multicenter, International, Open Label, Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B Cell Lymphoma $6,020 2 payments
A Randomized, Double Blind, Placebo Controlled, Parallel Group Phase 3 Study of Baricitinib in Patients With Covid 19 Infection $1,628 2 payments
Assessment of Safety Tolerability and Efficacy of Ly3372689 in Early Symptomatic Alzheimer's Disease $14 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.